Can antiplatelet therapy after drug eluting stent become a problem?
Many clinical trials demonstrate that demonstrate drug-eluting stents (DES) can improve procedural success in patients with acute coronary syndromes, with a remarkable reduction in the rate of restenosis. On the other hand, it has been shown that stenting can also increase the rate of thrombotic com...
| Published in: | Clinical Management Issues |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
SEEd
2009-03-01
|
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/556 |